Inhibitor compounds of phosphodiesterase type 10A

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9856220
SERIAL NO

15207137

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds which are inhibitors of phosphodiesterase type 10A and to their use for the manufacture of a medicament and which thus are suitable for treating or controlling of medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBVIE INC1 N WAUKEGAN ROAD NORTH CHICAGO IL 60064

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dinges, Jürgen North Chicago, US 17 86
Drescher, Karla Ludwigshafen, DE 77 265
Geneste, Hervé Ludwigshafen, DE 44 259
Jakob, Clarissa North Chicago, US 14 79
Ochse, Michael Ludwigshafen, DE 53 654

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 2, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 2, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00